Advertisement
Review| Volume 65, ISSUE 7, P903-910, July 2012

Why haematomas cause flap failure: An evidence-based paradigm

  • Graeme E. Glass
    Correspondence
    Corresponding author. Kennedy Institute of Rheumatology, University of Oxford, ARC Building, 65 Aspenlea Road, Hammersmith, London W6 8LH, UK. Tel.: +44 208 383 4763; fax: +44 208 383 4499.
    Affiliations
    Imperial College, London, UK

    Kennedy Institute of Rheumatology, University of Oxford, UK
    Search for articles by this author
  • Jagdeep Nanchahal
    Affiliations
    Kennedy Institute of Rheumatology, University of Oxford, UK
    Search for articles by this author
Published:January 09, 2012DOI:https://doi.org/10.1016/j.bjps.2011.12.014

      Summary

      Background

      Haematomas compromise flaps in the absence of a pressure effect and pedicle thrombosis. While animal models confirmed the toxic effect of whole blood on adjacently sited random pattern flaps, our understanding of this phenomenon remains incomplete. Our aim was to identify mechanisms by which a subjacent haematoma leads to flap compromise to inform clinical practice.

      Methods

      A literature review was conducted of all peer-reviewed publications relating haematoma to tissue compromise including free transferred tissue, vascularised flap models and brain injury. Clinical correlation was made with free vascularised flaps and rhytidectomy skin flaps.

      Results

      Haematomas compromise around 2–4% of free tissue transfers and local flaps. We propose that several mechanisms are responsible. Cytokines, generated by platelet degradation, recruit neutrophils, releasing both reactive oxygen species and proteolytic enzymes. Reactive oxygen species (ROS), including superoxide ( O 2 ) and hydroxyl (OH−) are also produced by ATP degradation, promoted by NAD+ sequestration. Additionally, the complement cascade is triggered by thrombin. Ferrous ions, freed by complement-mediated lysis of erythrocytes and degradation of haemoglobin also promote generation of ROS. Reactive oxygen species, complement and activated neutrophils cause endothelial cell disruption, leading to activation of pro-thrombotic mechanisms and small vessel occlusion, with consequent tissue ischaemia, which in turn generates further ROS.

      Conclusion

      Haematomas cause tissue injury by a complex sequence of inter-related biochemical and cellular processes merging on a common pathway of local tissue ischaemia which the overlying tissue is unable to regulate. Emergent evacuation of haematoma must be considered irrespective of envelope tension.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bui D.T.
        • Cordeiro P.G.
        • Hu Q.Y.
        • et al.
        Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps.
        Plast Reconstr Surg. 2007; 119: 2092-2100
        • Mulliken J.B.
        • Healey N.A.
        • Murray J.E.
        An experimental study of hematoma and flap necrosis.
        Surg Forum. 1977; 28: 531-533
        • Brown J.S.
        • Devine J.C.
        • Magennis P.
        • et al.
        Factors that influence the outcome of salvage in free tissue transfer.
        Br J Oral Maxillofac Surg. 2003; 41: 16-20
        • Khouri R.K.
        • Cooley B.C.
        • Kunselman A.R.
        • et al.
        A prospective study of microvascular free-flap surgery and outcome.
        Plast Reconstr Surg. 1998; 102: 711-721
        • Khouri R.K.
        • Sherman R.
        • Buncke Jr., H.J.
        • et al.
        A phase II trial of intraluminal irrigation with recombinant human tissue factor pathway inhibitor to prevent thrombosis in free flap surgery.
        Plast Reconstr Surg. 2001; 107 (discussion 416–408): 408-415
        • Kroll S.S.
        • Miller M.J.
        • Reece G.P.
        • et al.
        Anticoagulants and hematomas in free flap surgery.
        Plast Reconstr Surg. 1995; 96: 643-647
        • Nakatsuka T.
        • Harii K.
        • Asato H.
        • et al.
        Analytic review of 2372 free flap transfers for head and neck reconstruction following cancer resection.
        J Reconstr Microsurg. 2003; 19 (discussion 369): 363-368
        • Schusterman M.A.
        • Miller M.J.
        • Reece G.P.
        • et al.
        A single center’s experience with 308 free flaps for repair of head and neck cancer defects.
        Plast Reconstr Surg. 1994; 93 (discussion 479–480): 472-478
        • Yu P.
        • Chang D.W.
        • Miller M.J.
        • et al.
        Analysis of 49 cases of flap compromise in 1310 free flaps for head and neck reconstruction.
        Head Neck. 2009; 31: 45-51
        • Matarasso A.
        • Elkwood A.
        • Rankin M.
        • et al.
        National plastic surgery survey: face lift techniques and complications.
        Plast Reconstr Surg. 2000; 106 (discussion 1196): 1185-1195
        • Baker D.C.
        • Stefani W.A.
        • Chiu E.S.
        Reducing the incidence of hematoma requiring surgical evacuation following male rhytidectomy: a 30-year review of 985 cases.
        Plast Reconstr Surg. 2005; 116 (discussion 1986–1977): 1973-1985
        • Baker T.J.
        • Gordon H.L.
        • Mosienko P.
        Rhytidectomy: a statistical analysis.
        Plast Reconstr Surg. 1977; 59: 24-30
        • Beer G.M.
        • Goldscheider E.
        • Weber A.
        • et al.
        Prevention of acute hematoma after face-lifts.
        Aesthetic Plast Surg. 2010; 34: 502-507
        • Durnig P.
        • Jungwirth W.
        Low-molecular-weight heparin and postoperative bleeding in rhytidectomy.
        Plast Reconstr Surg. 2006; 118 (discussion 508–509): 502-507
        • Griffin J.E.
        • Jo C.
        Complications after superficial plane cervicofacial rhytidectomy: a retrospective analysis of 178 consecutive facelifts and review of the literature.
        J Oral Maxillofac Surg. 2007; 65: 2227-2234
        • Grover R.
        • Jones B.M.
        • Waterhouse N.
        The prevention of haematoma following rhytidectomy: a review of 1078 consecutive facelifts.
        Br J Plast Surg. 2001; 54: 481-486
        • Heinrichs H.L.
        • Kaidi A.A.
        Subperiosteal face lift: a 200-case, 4-year review.
        Plast Reconstr Surg. 1998; 102: 843-855
        • Jones B.M.
        • Grover R.
        Avoiding hematoma in cervicofacial rhytidectomy: a personal 8-year quest. Reviewing 910 patients.
        Plast Reconstr Surg. 2004; 113 (discussion 388–390): 381-387
        • Kamer F.M.
        • Song A.U.
        Hematoma formation in deep plane rhytidectomy.
        Arch Facial Plast Surg. 2000; 2: 240-242
        • Lawson W.
        • Naidu R.K.
        The male facelift. An analysis of 115 cases.
        Arch Otolaryngol Head Neck Surg. 1993; 119 (discussion 540–531): 535-539
        • Leist F.D.
        • Masson J.K.
        • Erich J.B.
        A review of 324 rhytidectomies, emphasizing complications and patient dissatisfaction.
        Plast Reconstr Surg. 1977; 59: 525-529
        • Niamtu 3rd, J.
        Expanding hematoma in face-lift surgery: literature review, case presentations, and caveats.
        Dermatol Surg. 2005; 31 (discussion 1144): 1134-1144
        • Pitanguy I.
        • Ceravolo M.P.
        Hematoma postrhytidectomy: how we treat it.
        Plast Reconstr Surg. 1981; 67: 526-529
        • Rees T.D.
        • Barone C.M.
        • Valauri F.A.
        • et al.
        Hematomas requiring surgical evacuation following face lift surgery.
        Plast Reconstr Surg. 1994; 93: 1185-1190
        • Thompson D.P.
        • Ashley F.L.
        Face-lift complications: a study of 922 cases performed in a 6-year period.
        Plast Reconstr Surg. 1978; 61: 40-49
        • Zager W.H.
        • Dyer W.K.
        Minimal incision facelift.
        Facial Plast Surg. 2005; 21: 21-27
        • Zoumalan R.
        • Rizk S.S.
        Hematoma rates in drainless deep-plane face-lift surgery with and without the use of fibrin glue.
        Arch Facial Plast Surg. 2008; 10: 103-107
        • Mulliken J.B.
        • Healey N.A.
        Pathogenesis of skin flap necrosis from an underlying hematoma.
        Plast Reconstr Surg. 1979; 63: 540-545
        • Hillelson R.L.
        • Glowacki J.
        • Healey N.A.
        • et al.
        A microangiographic study of hematoma-associated flap necrosis and salvage with isoxsuprine.
        Plast Reconstr Surg. 1980; 66: 528-533
        • Arslan H.
        • Cinar C.
        • Bingol U.A.
        • et al.
        The effect of hematoma in muscle flap microcirculation.
        Ann Plast Surg. 2007; 59: 195-200
        • Hallenbeck J.M.
        Inflammatory reactions at the blood-endothelial interface in acute stroke.
        Adv Neurol. 1996; 71 (discussion 297–300): 281-297
        • Carroll W.R.
        • Esclamado R.M.
        Ischemia/reperfusion injury in microvascular surgery.
        Head Neck. 2000; 22: 700-713
        • Bagge U.
        • Amundson B.
        • Lauritzen C.
        White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock.
        Acta Physiol Scand. 1980; 108: 159-163
        • Siemionow M.
        • Arslan E.
        Ischemia/reperfusion injury: a review in relation to free tissue transfers.
        Microsurgery. 2004; 24: 468-475
        • Doyle K.P.
        • Simon R.P.
        • Stenzel-Poore M.P.
        Mechanisms of ischemic brain damage.
        Neuropharmacology. 2008; 55: 310-318
        • Libby P.
        • Ordovas J.M.
        • Auger K.R.
        • et al.
        Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.
        Am J Pathol. 1986; 124: 179-185
        • Iadecola C.
        • Alexander M.
        Cerebral ischemia and inflammation.
        Curr Opin Neurol. 2001; 14: 89-94
        • Nawashiro H.
        • Martin D.
        • Hallenbeck J.M.
        Neuroprotective effects of TNF binding protein in focal cerebral ischemia.
        Brain Res. 1997; 778: 265-271
        • Yamasaki Y.
        • Matsuura N.
        • Shozuhara H.
        • et al.
        Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats.
        Stroke. 1995; 26 (discussion 681): 676-680
        • Schindler R.
        • Mancilla J.
        • Endres S.
        • et al.
        Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.
        Blood. 1990; 75: 40-47
        • Kerrigan C.L.
        • Stotland M.A.
        Ischemia reperfusion injury: a review.
        Microsurgery. 1993; 14: 165-175
        • Nakamura S.
        • Imamura T.
        • Okamoto K.
        Tissue factor in neutrophils: yes.
        J Thromb Haemost. 2004; 2: 214-217
        • Suzuki S.
        • Isshiki N.
        • Ogawa Y.
        • et al.
        The minimal requirement of circulation for survival of undelayed and delayed flaps in rats.
        Plast Reconstr Surg. 1986; 78: 221-227
        • Manson P.N.
        • Anthenelli R.M.
        • Im M.J.
        • et al.
        The role of oxygen-free radicals in ischemic tissue injury in island skin flaps.
        Ann Surg. 1983; 198: 87-90
        • Angel M.F.
        • Narayanan K.
        • Swartz W.M.
        • et al.
        The etiologic role of free radicals in hematoma-induced flap necrosis.
        Plast Reconstr Surg. 1986; 77: 795-803
        • Diaz D.D.
        • Freeman S.B.
        • Wilson J.F.
        • et al.
        Hematoma-induced flap necrosis and free radical scavengers.
        Arch Otolaryngol Head Neck Surg. 1992; 118: 516-518
        • Suzuki S.
        • Miyachi Y.
        • Niwa Y.
        • et al.
        Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD.
        Br J Plast Surg. 1989; 42: 559-564
        • Suzuki S.
        • Yoshioka N.
        • Isshiki N.
        • et al.
        Involvement of reactive oxygen species in post-ischaemic flap necrosis and its prevention by antioxidants.
        Br J Plast Surg. 1991; 44: 130-134
        • Halliwell B.
        • JMC G.
        Free radicals in biology and medicine.
        2nd ed. Clarendon Press, Oxford1989
        • McCord J.M.
        Oxygen-derived free radicals in postischemic tissue injury.
        N Engl J Med. 1985; 312: 159-163
        • Halliwell B.
        Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?.
        Lancet. 1994; 344: 721-724
        • Ducruet A.F.
        • Zacharia B.E.
        • Hickman Z.L.
        • et al.
        The complement cascade as a therapeutic target in intracerebral hemorrhage.
        Exp Neurol. 2009; 219: 398-403
        • Yang S.
        • Nakamura T.
        • Hua Y.
        • et al.
        The role of complement C3 in intracerebral hemorrhage-induced brain injury.
        J Cereb Blood Flow Metab. 2006; 26: 1490-1495
        • Arumugam T.V.
        • Shiels I.A.
        • Woodruff T.M.
        • et al.
        The role of the complement system in ischemia-reperfusion injury.
        Shock. 2004; 21: 401-409
        • Lee K.R.
        • Colon G.P.
        • Betz A.L.
        • et al.
        Edema from intracerebral hemorrhage: the role of thrombin.
        J Neurosurg. 1996; 84: 91-96
        • Salmi A.
        • Tukiainen E.
        • Harma M.
        • et al.
        A prospective study of changes in muscle dimensions following free-muscle transfer measured by ultrasound and CT scanning.
        Plast Reconstr Surg. 1996; 97: 1443-1450
        • Stotland M.A.
        • Kerrigan C.L.
        The role of platelet-activating factor in musculocutaneous flap reperfusion injury.
        Plast Reconstr Surg. 1997; 99 (discussion 2000–1981): 1989-1999